Catherine Rogers

3.3k total citations
29 papers, 1.7k citations indexed

About

Catherine Rogers is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Catherine Rogers has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Hematology and 4 papers in Oncology. Recurrent topics in Catherine Rogers's work include Protein Degradation and Inhibitors (15 papers), Multiple Myeloma Research and Treatments (12 papers) and Histone Deacetylase Inhibitors Research (7 papers). Catherine Rogers is often cited by papers focused on Protein Degradation and Inhibitors (15 papers), Multiple Myeloma Research and Treatments (12 papers) and Histone Deacetylase Inhibitors Research (7 papers). Catherine Rogers collaborates with scholars based in United Kingdom, United States and Germany. Catherine Rogers's co-authors include Jacqueline A. Lees, Susanne Müller, Stefan Knapp, Patrick O. Humbert, Savita Dandapani, Jeffrey M. Trimarchi, Paul E. Brennan, C. Tallant, Raluca Verona and Octovia Monteiro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Catherine Rogers

27 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Rogers United Kingdom 20 1.3k 466 409 159 135 29 1.7k
Charles J. Dimitroff United States 32 1.5k 1.2× 713 1.5× 203 0.5× 235 1.5× 212 1.6× 56 2.8k
John C. Byrd United States 27 1.7k 1.3× 271 0.6× 316 0.8× 54 0.3× 324 2.4× 56 2.1k
Pavel Klener Czechia 25 631 0.5× 638 1.4× 154 0.4× 61 0.4× 146 1.1× 121 1.6k
Jian Ren United States 26 2.0k 1.5× 655 1.4× 108 0.3× 204 1.3× 301 2.2× 33 2.5k
Monica M. Burdick United States 20 674 0.5× 425 0.9× 145 0.4× 43 0.3× 165 1.2× 48 1.4k
Melanie Cornejo United States 11 1.0k 0.8× 381 0.8× 278 0.7× 114 0.7× 104 0.8× 19 1.6k
Ludovic Martinet France 23 739 0.6× 1.8k 3.9× 369 0.9× 73 0.5× 147 1.1× 36 3.4k
Darren G. Woodside United States 24 763 0.6× 219 0.5× 199 0.5× 51 0.3× 114 0.8× 45 1.9k
Inja Waldhauer Switzerland 10 741 0.6× 852 1.8× 120 0.3× 50 0.3× 108 0.8× 22 2.3k
Boris Klebanov United States 15 1.1k 0.9× 214 0.5× 213 0.5× 78 0.5× 204 1.5× 49 1.6k

Countries citing papers authored by Catherine Rogers

Since Specialization
Citations

This map shows the geographic impact of Catherine Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Rogers more than expected).

Fields of papers citing papers by Catherine Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Rogers. The network helps show where Catherine Rogers may publish in the future.

Co-authorship network of co-authors of Catherine Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Rogers. A scholar is included among the top collaborators of Catherine Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Rogers. Catherine Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Usha, James D. Vasta, Michael Beck, et al.. (2025). A BRET biosensor for measuring uncompetitive engagement of PRMT5 complexes in cells. Nature Communications. 16(1). 10129–10129.
2.
Ward, Jennifer, Yvonne Sundström, Sarantos Kostidis, et al.. (2024). Phenomics‐Based Discovery of Novel Orthosteric Choline Kinase Inhibitors. Angewandte Chemie International Edition. 64(7). e202420149–e202420149.
3.
Bennett, James M., Usha Singh, Catherine Rogers, et al.. (2024). Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. Journal of Medicinal Chemistry. 67(9). 7245–7259. 4 indexed citations
4.
Martinelli, Paola, Otmar Schaaf, Andreas Mantoulidis, et al.. (2023). Discovery of a Chemical Probe to Study Implications of BPTF Bromodomain Inhibition in Cellular and in vivo Experiments. ChemMedChem. 18(6). e202200686–e202200686. 3 indexed citations
5.
Rogers, Catherine, et al.. (2019). Coarctation of the aorta. JAAPA. 32(6). 46–47. 3 indexed citations
6.
Liu, Joyce F., Shibani Nicum, Peter Reichardt, et al.. (2018). Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer. Gynecologic Oncology. 150(1). 173–179. 20 indexed citations
7.
Yapp, Clarence, Catherine Rogers, P. Savitsky, Martin Philpott, & Susanne Müller. (2016). Frapid: achieving full automation of FRAP for chemical probe validation. Biomedical Optics Express. 7(2). 422–422. 2 indexed citations
8.
Clark, Peter G. K., Lucas Campos Curcino Vieira, C. Tallant, et al.. (2015). LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor. Angewandte Chemie. 127(21). 6315–6319. 111 indexed citations
9.
Clark, Peter G. K., Lucas Campos Curcino Vieira, C. Tallant, et al.. (2015). LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor. Angewandte Chemie International Edition. 54(21). 6217–6221. 134 indexed citations
10.
Bennett, James M., Oleg Fedorov, C. Tallant, et al.. (2015). Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF. Journal of Medicinal Chemistry. 59(4). 1642–1647. 82 indexed citations
11.
Rooney, Timothy P. C., P. Filippakopoulos, O. Fedorov, et al.. (2014). A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced‐Fit Pocket Stabilized by a Cation–π Interaction. Angewandte Chemie. 126(24). 6240–6244. 13 indexed citations
12.
Rooney, Timothy P. C., P. Filippakopoulos, O. Fedorov, et al.. (2014). A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced‐Fit Pocket Stabilized by a Cation–π Interaction. Angewandte Chemie International Edition. 53(24). 6126–6130. 93 indexed citations
13.
Rogers, Catherine, G E Morris, Sotiria Toumpaniari, et al.. (2014). A novel technique for the production of electrospun scaffolds with tailored three-dimensional micro-patterns employing additive manufacturing. Biofabrication. 6(3). 35003–35003. 47 indexed citations
14.
Philpott, Martin, Catherine Rogers, Clarence Yapp, et al.. (2014). Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching. Epigenetics & Chromatin. 7(1). 14–14. 49 indexed citations
15.
Hay, Duncan A., Oleg Fedorov, Sarah Martin, et al.. (2014). Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains. Journal of the American Chemical Society. 136(26). 9308–9319. 208 indexed citations
16.
Dixon, James E., Disheet Shah, Catherine Rogers, et al.. (2014). Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation. Proceedings of the National Academy of Sciences. 111(15). 5580–5585. 62 indexed citations
17.
Rogers, Catherine, et al.. (2013). Biocompatibility and enhanced osteogenic differentiation of human mesenchymal stem cells in response to surface engineered poly(d,l-lactic-co-glycolic acid) microparticles. Journal of Biomedical Materials Research Part A. 102(11). 3872–3882. 6 indexed citations
18.
Rogers, Catherine, Tammi L. Reza, Ulrike Ziebold, et al.. (2002). Mutant Mouse Models Reveal the Relative Roles of E2F1 and E2F3 In Vivo. Molecular and Cellular Biology. 22(8). 2663–2672. 74 indexed citations
19.
Humbert, Patrick O., Catherine Rogers, Soula Ganiatsas, et al.. (2000). E2F4 Is Essential for Normal Erythrocyte Maturation and Neonatal Viability. Molecular Cell. 6(2). 281–291. 150 indexed citations
20.
Krauss, Sharon Wald, Joel Anne Chasis, Catherine Rogers, et al.. (1997). Structural protein 4.1 is located in mammalian centrosomes. Proceedings of the National Academy of Sciences. 94(14). 7297–7302. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles J. Dimitroff Breakdown of academic impact, for papers by John C. Byrd Breakdown of academic impact, for papers by Pavel Klener Breakdown of academic impact, for papers by Jian Ren Breakdown of academic impact, for papers by Monica M. Burdick Breakdown of academic impact, for papers by Melanie Cornejo Breakdown of academic impact, for papers by Ludovic Martinet Breakdown of academic impact, for papers by Darren G. Woodside Breakdown of academic impact, for papers by Inja Waldhauer Breakdown of academic impact, for papers by Boris Klebanov
Rankless by CCL
2026